Efficacy and safety of fluticasone furoate nasal spray in Chinese adult and adolescent subjects with intermittent or persistent allergic rhinitis

Allergy and Asthma Proceedings

Volumn 32, Issue 6, 2011, Pages 472-481

  Han, Demin ^a,b   Liu, Shixi ^c   Zhang, Yuan ^a   Wang, Jiadong ^d   Wang, Dehui ^e   Kong, Weijia ^f   Wang, Shenqing ^g   Cheng, Lei ^h   Zhang, Luo ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e FUDAN UNIVERSITY   (China)

^f UNION HOSPITAL   (China)

^g ZHEJIANG UNIVERSITY   (China)

^h NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE FUROATE; PLACEBO;

ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; ADOLESCENT; ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; COUGHING; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; GASTROINTESTINAL SYMPTOM; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUROLOGIC DISEASE; NOSE DISEASE; PATIENT COMPLIANCE; PERENNIAL RHINITIS; RANDOMIZED CONTROLLED TRIAL; RHINALGIA; SCORING SYSTEM; THROAT IRRITATION; TOTAL NASAL SYMPTOM SCORE; TOTAL OCULAR SYMPTOM SCORE; UPPER RESPIRATORY TRACT INFECTION; XEROSTOMIA;

ADOLESCENT; ADULT; ANDROSTADIENES; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL SPRAYS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84355167605     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3474     Document Type: Article

References (30)

1. 2LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
2. Bernstein JA. Allergic and mixed rhinitis: Epidemiology and natural history. Allergy Asthma Proc 31:365-369, 2010.
3. Zhang L, Han D, Huang D, et al. Prevalence of self-reported allergic rhinitis in eleven major cities in china. Int Arch Allergy Immunol 149:47-57, 2009.
4. Broide DH. Allergic rhinitis: Pathophysiology. Allergy Asthma Proc 31:370-374, 2010.
5. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 124(suppl):S43-S70, 2009.
6. Lv X, Xi L, Han D, and Zhang L. Evaluation of the psychological status in seasonal allergic rhinitis patients. ORL J Otorhinolaryngol Relat Spec 72:84-90, 2010.
7. Lv X, Han D, Xi L, and Zhang L. Psychological aspects of female patients with moderate-to-severe persistent allergic rhinitis. ORL J Otorhinolaryngol Relat Spec 72:235-241, 2010.
8. Blaiss MS. Allergic rhinitis: Direct and indirect costs. Allergy Asthma Proc 31:375-380, 2010.
9. Benninger MS, and Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc 30:358-365, 2009.
10. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: Findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 30:244-254, 2009.
11. Nathan RA, Meltzer EO, Derebery J, et al. The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 29:600-608, 2008.
12. Salter M, Biggadike K, Matthews JL, et al. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 293:L660-L667, 2007. (Pubitemid 47358828)
13. Scadding GK, and Keith PK. Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: A review of the clinical data. Expert Opin Pharmacother 9:2707-2715, 2008.
14. Fokkens WJ, Jogi R, Reinartz S, al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 62:1078-1084, 2007. (Pubitemid 47220983)
15. Kaiser HB, Naclerio RM, Given J, et al. Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 119:1430-1437, 2007. (Pubitemid 46855849)
16. Jacobs R, Martin B, Hampel F, et al. Effectiveness of fluticasone furoate 110mg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. Curr Med Res Opin 25: 1393-1401, 2009.
17. Meltzer EO, Lee J, Tripathy I, et al. Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. Pediatr Allergy Immunol 20:279-286, 2009.
18. Maspero JF, Rosenblut A, Finn A, et al. Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis. Otolaryngol Head Neck Surg 138:30-37, 2008. (Pubitemid 350299657)
19. Nathan RA, Berger W, Yang W, et al. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol 100:497-505, 2008. (Pubitemid 351668788)
20. Vasar M, Houle PA, Meltzer EO, et al. Fluticasone furoate nasal spray: Effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents. Allergy Asthma Proc 29:313-321, 2008.
21. Maspero JF, Walters RD, Wu WW, et al. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc 31:483-492, 2010.
22. Rodrigo GJ, and Neffen H. Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review. Clin Exp Allergy 41:160-170, 2011.
23. Baroody FM, Shenaq D, DeTineo M, et al. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: A mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol 123:1342-1348, 2009.
24. Keith PK, and Scadding GK. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr Med Res Opin 25:2021-2024, 2009.
25. Bernstein DI, Levy AL, Hampel FC, et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 34:952-957, 2004. (Pubitemid 38824075)
26. Bielory L. Ocular symptom reduction in patients with seasonal rhinitis treated with the intranasal corticosteroid mometasone fuorate. Ann Allergy Asthma Immunol 100:272-279, 2008. (Pubitemid 351398007)
27. Prenner BM, Lanier BQ, Bernstein DI, et al. Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 125:1247-1253, 2010.
28. Hong J, Bielory B, Rosenberg JL, and Bielory L. Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: A systematic review. Allergy Asthma Proc 32:22-35, 2011.
29. Anolik R, Pearlman D, Teper A, and Gates D. Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents. Allergy Asthma Proc 30:406-412, 2009.
30. Rosenblut A, Bardin PG, Muller B, et al. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 62:1071-1077, 2007. (Pubitemid 47220982)